Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
Tiziano Barbui(University of Bergamo), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Paola Guglielmelli(Azienda Ospedaliero-Universitaria Careggi), Alessandra Carobbio(Ospedale Papa Giovanni XXIII), Oscar Borsani(Policlinico San Matteo Fondazione), Maria Chiara Finazzi(Ospedale Papa Giovanni XXIII), Marco Brociner(Ospedale di Circolo e Fondazione Macchi), Daniele Vanni(Istituti di Ricovero e Cura a Carattere Scientifico), Greta Carioli(Ospedale Papa Giovanni XXIII), Arianna Masciulli(Ospedale Papa Giovanni XXIII), Ana Triguero(Hospital Clínic de Barcelona), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Marta Garrote(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Arianna Ghirardi(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Chiara Paoli(University of Genoa), Elisa Rumi(University of Pavia), Helna Pettersson(NU Hospital Group), Giovanni Barosi(Policlinico San Matteo Fondazione), Barbara Mora(Casa Sollievo della Sofferenza), Alberto Álvarez‐Larrán(Hospital Clínic de Barcelona), Marta Bellini(University of Pavia), Francesco Passamonti(University of Milan)
Cited by 14
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k